Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1

SIMPLE SUMMARY: A novel biomarker panel (Appl1, Sortilin and Syndecan-1) was demonstrated as a strong independent predictor for both clinical and biochemical recurrence outcomes, with a higher prediction performance than traditional grading. This suggests that panel-derived patient reclassifications...

Descripción completa

Detalles Bibliográficos
Autores principales: Logan, Jessica M., Hopkins, Ashley M., Martini, Carmela, Sorvina, Alexandra, Tewari, Prerna, Prabhakaran, Sarita, Huzzell, Chelsea, Johnson, Ian R. D., Hickey, Shane M., Ung, Ben S.-Y., Lazniewska, Joanna, Brooks, Robert D., Moore, Courtney R., Caruso, Maria C., Karageorgos, Litsa, Martin, Cara M., O’Toole, Sharon, Bogue Edgerton, Laura, Ward, Mark P., Bates, Mark, Selemidis, Stavros, Esterman, Adrian, Heffernan, Sheena, Keegan, Helen, Ní Mhaolcatha, Sarah, O’Connor, Roisin, Malone, Victoria, Carter, Marguerite, Ryan, Katie, Clarke, Andres, Brady, Nathan, Klebe, Sonja, Samaratunga, Hemamali, Delahunt, Brett, Sorich, Michael J., Moretti, Kim, Butler, Lisa M., O’Leary, John J., Brooks, Douglas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296524/
https://www.ncbi.nlm.nih.gov/pubmed/37370825
http://dx.doi.org/10.3390/cancers15123215

Ejemplares similares

Ejemplares similares